eFFECTOR Therapeutics is a clinical-stage biopharmaceutical company focused on pioneering the discovery and development of a new class of oncology drugs known as selective translation regulators (STRs).

Biotechnology

eFFECTOR Therapeutics

Steve Worland

Austin McNutt

Katie Ard

Thomas Kevin Gregorczyk

Gary Chiang

Sam Sperry

Doug Warner

The Advisory Team at eFFECTOR Therapeutics comprises highly experienced professionals who provide strategic guidance and expert insights to support the discovery and development of selective translation regulators (STRs). Their collective expertise ensures the company’s oncology drugs progress effectively through clinical stages, aligning with eFFECTOR’s mission and regulatory standards.

Advisory Team

Leadership Team

Advisory Team

About

Team members

Other teams at eFFECTOR Therapeutics

Leadership Team